Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
NCT01414595 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 248
Last updated 2017-06-27
Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research trial studies tissue samples from patients with non-small cell lung cancer.
Conditions
Interventions
- GENETIC
-
DNA analysis
- GENETIC
-
DNA methylation analysis
- GENETIC
-
RNA analysis
- GENETIC
-
gene expression analysis
- GENETIC
-
polymorphism analysis
- OTHER
-
laboratory biomarker analysis
- OTHER
-
medical chart review
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Alliance for Clinical Trials in Oncology
lead OTHER
Principal Investigators
-
Ramaswamy Govindan, MD · Washington University School of Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2017-02-28
Countries
- United States
Study Locations
More Related Trials
-
Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung Cancer
NCT01415739 ·Status: WITHDRAWN
-
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
NCT00899028 ·Status: COMPLETED
-
Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants
NCT00899457 ·Status: COMPLETED
-
Detection of Genetic Markers of Lung Cancer
NCT00280202 ·Status: RECRUITING
-
Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer
NCT00340847 ·Status: COMPLETED
-
Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease
NCT01450553 ·Status: UNKNOWN
-
Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients
NCT02113852 ·Status: COMPLETED
-
Study of Tumor Samples From Patients With Lung Cancer
NCT00900328 ·Status: COMPLETED
-
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
NCT02597738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Lung Tumor Protein Synthesis Rates in Lung Cancer Patients
NCT05794529 ·Status: RECRUITING
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program
NCT03628638 ·Status: COMPLETED
-
Lung Cancer Early Molecular Assessment Trial
NCT02894853 ·Status: UNKNOWN
-
Collection of Blood Samples in Patients With Non-small Cell Lung Cancer
NCT03492801 ·Status: TERMINATED
-
Genotyping of Non-small Cell Lung Cancer
NCT02002117 ·Status: UNKNOWN
-
Specimen Banking From Patients With Lung Cancer
NCT01585675 ·Status: RECRUITING
-
Circulating Tumor DNA in Patients at High Risk for Lung Cancer
NCT02715102 ·Status: TERMINATED
-
Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA
NCT03499678 ·Status: TERMINATED
-
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT01580982 ·Status: RECRUITING
-
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
NCT03791034 ·Status: RECRUITING
-
Liquid Biopsy for Early Non-small Lung Cancer Detection
NCT05462795 ·Status: COMPLETED
-
Liquid Biopsy in Lung Cancer
NCT03479099 ·Status: COMPLETED
-
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
NCT05415358 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
NCT00003006 ·Status: COMPLETED
-
Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)
NCT01173458 ·Status: COMPLETED